Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P 500 Capped 35/20 Health Care |
| Investment focus | Equity, United States, Health Care |
| Fund size | EUR 2,354 m |
| Total expense ratio | 0.15% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 17.53% |
| Inception/ Listing Date | 20 November 2015 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 30 November |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| Eli Lilly & Co. | 12.79% |
| Johnson & Johnson | 8.68% |
| AbbVie, Inc. | 7.68% |
| UnitedHealth Group | 5.95% |
| Abbott Laboratories | 4.14% |
| Merck & Co., Inc. | 4.11% |
| Thermo Fisher Scientific | 4.00% |
| Intuitive Surgical | 3.62% |
| Amgen, Inc. | 3.00% |
| Boston Scientific Corp. | 2.84% |
| United States | 95.56% |
| Ireland | 2.66% |
| Other | 1.78% |
| Health Care | 98.22% |
| Other | 1.78% |
| YTD | +2.27% |
| 1 month | +2.76% |
| 3 months | +9.54% |
| 6 months | +18.31% |
| 1 year | +2.57% |
| 3 years | +8.55% |
| 5 years | +53.92% |
| Since inception (MAX) | +134.57% |
| 2025 | +0.96% |
| 2024 | +8.63% |
| 2023 | -1.84% |
| 2022 | +3.70% |
| Volatility 1 year | 17.53% |
| Volatility 3 years | 14.74% |
| Volatility 5 years | 15.66% |
| Return per risk 1 year | 0.15 |
| Return per risk 3 years | 0.19 |
| Return per risk 5 years | 0.57 |
| Maximum drawdown 1 year | -22.33% |
| Maximum drawdown 3 years | -22.33% |
| Maximum drawdown 5 years | -22.33% |
| Maximum drawdown since inception | -27.77% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| London Stock Exchange | GBX | IHCU | - - | - - | - |
| gettex | EUR | QDVG | - - | - - | - |
| Stuttgart Stock Exchange | EUR | QDVG | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | IUHCN MM | IUHCN.MX | |
| London Stock Exchange | USD | IUHC | IUHC LN INAVIHCU | IHCU.L 3094INAV.DE | |
| London Stock Exchange | GBP | - | IHCU LN INAVIHCG | IUHC.L 3092INAV.DE | |
| SIX Swiss Exchange | USD | IUHC | IUHC SE INAVIHCU | IUHC.S 3094INAV.DE | |
| XETRA | EUR | QDVG | QDVG GY INAVIHCE | QDVG.DE 309ZINAV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 44 | 0.35% p.a. | Distributing | Sampling |